The global market for diabetes care devices is forecast to reach US $16 billion by 2030 with a growing compound annual growth rate (CAGR) of 6.5% during the forecast period 2021-2030. In 2020, the ...
Request To Download Free Sample of This Strategic Report @ The publisher has been vigilantly tracking the diverse markets within Saudi Arabia. This report presents an extensive analysis, encompassing ...
Eli Lilly stock has soared on a new growth wave driven by its diabetes and obesity care treatments. While this has made profit-taking in Lilly stock tempting, the company has several catalysts ahead.
Novo Nordisk, Europe's most valuable listed company, has reported significant success with its diabetes medication Rybelsus. A recent Phase III study demonstrated that the active ingredient semaglutid ...